La Jolla, CA – According to filings with the U.S. Securities and Exchange Commission, Carlsmed is raising $12,643,855.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Cordonnier played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Carlsmed

Carlsmed is leveraging data to personalize the treatment of complex adult spinal deformities. The company’s proprietary aprevo devices are tailored to the precise medical situation of every individual patient. This is transforming healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles.

To learn more about Carlsmed, visit http://carlsmed.com/

Contact:
Michael Cordonnier, Chief Executive Officer
760-766-1923
https://www.linkedin.com/in/mikecordonnier/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved